We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.51B
AUM Growth
+$620M
Cap. Flow
+$586M
Cap. Flow %
38.86%
Top 10 Hldgs %
20.25%
Holding
396
New
278
Increased
36
Reduced
41
Closed
8

Top Buys

Rank Stock Value
1
GDRX icon
GoodRx Holdings
GDRX
+$34.4M
2
THO icon
Thor Industries
THO
+$24.3M
3
LHCG
LHC Group LLC
LHCG
+$22M
4
LH icon
Labcorp
LH
+$21.2M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$21.2M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$19.6M
2
INMD icon
InMode
INMD
+$19M
3
BEAT
BioTelemetry, Inc.
BEAT
+$18M
4
DXCM icon
DexCom
DXCM
+$11.4M
5
FUTU icon
Futu Holdings
FUTU
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 45.22%
2 Consumer Discretionary 13.83%
3 Financials 12.23%
4 Technology 6.87%
5 Communication Services 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
1
Charles Schwab
SCHW
$186B
$36.5M 2.42%
559,915
-37,465
-6% -$2.27M
LOW icon
2
Lowe's Companies
LOW
$125B
$34.5M 2.29%
181,375
+589
+0.3% +$101K
AXP icon
3
American Express
AXP
$230B
$32.9M 2.18%
232,619
-27,303
-11% -$3.61M
TMO icon
4
Thermo Fisher Scientific
TMO
$222B
$30.7M 2.04%
67,285
+490
+0.7% +$234K
HOLX
5
DELISTED
Hologic
HOLX
$30M 1.99%
403,141
+100,000
+33% +$7.59M
GDRX icon
6
GoodRx Holdings
GDRX
$1.28B
$29.8M 1.98%
+764,779
New +$34.4M
KEYS icon
7
Keysight
KEYS
$58.9B
$29.3M 1.94%
204,138
-19,642
-9% -$2.79M
EXAS
8
DELISTED
Exact Sciences
EXAS
$28.3M 1.88%
214,610
+144,610
+207% +$19.8M
THO icon
9
Thor Industries
THO
$4.16B
$26.9M 1.79%
+200,000
New +$24.3M
PHM icon
10
Pultegroup
PHM
$25B
$26.3M 1.74%
500,624
-2,053
-0.4% -$95.8K
VOYA icon
11
Voya Financial
VOYA
$8.97B
$26.2M 1.74%
411,464
-88,692
-18% -$5.33M
SCI icon
12
Service Corp International
SCI
$11.4B
$25.5M 1.69%
500,000
+70,000
+16% +$3.51M
V icon
13
Visa
V
$679B
$25.5M 1.69%
120,378
-35,511
-23% -$7.47M
MRK icon
14
Merck
MRK
$321B
$24.5M 1.63%
333,061
-32,761
-9% -$2.42M
ABT icon
15
Abbott
ABT
$190B
$23.7M 1.57%
197,420
+32,228
+20% +$3.82M
IQV icon
16
IQVIA
IQV
$40B
$23.5M 1.56%
121,688
-50,172
-29% -$9.42M
FUTU icon
17
Futu Holdings
FUTU
$14.8B
$23.2M 1.54%
146,000
-81,400
-36% -$10.1M
LH icon
18
Labcorp
LH
$26.2B
$23.2M 1.54%
+105,795
New +$21.2M
ABBV icon
19
AbbVie
ABBV
$439B
$23M 1.53%
212,829
-88,172
-29% -$9.43M
CHE icon
20
Chemed
CHE
$7.19B
$23M 1.53%
50,000
+15,000
+43% +$7.35M
NTLA icon
21
Intellia Therapeutics
NTLA
$1.66B
$22.7M 1.51%
+282,953
New +$19M
BC icon
22
Brunswick
BC
$5.27B
$21.9M 1.46%
230,000
+95,000
+70% +$8.71M
LHCG
23
DELISTED
LHC Group LLC
LHCG
$21M 1.4%
+110,000
New +$22M
BIDU icon
24
Baidu
BIDU
$35.9B
$20.9M 1.39%
96,125
-3,675
-4% -$959K
TNDM icon
25
Tandem Diabetes Care
TNDM
$1.58B
$20.1M 1.34%
+228,331
New +$21.2M
1
2 3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q1 2021 Portfolio in Review

As of Q1 2021, Lombard Odier Asset Management (Switzerland) held 396 positions worth $1.51B, up 70% from $887M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $586M of net new capital in Q1 2021, opening 278 new positions and adding to 36 existing holdings. Its largest new stake was GoodRx Holdings: 764,779 shares worth $29.8M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Futu Holdings, an estimated $10.1M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q1 2021 buy was GoodRx Holdings: 764,779 shares worth $29.8M.
  • Lombard Odier Asset Management (Switzerland) added most to Exact Sciences in Q1 2021, an estimated $19.8M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $10.1M.
  • Lombard Odier Asset Management (Switzerland) fully exited HILL-ROM HOLDINGS, INC. in Q1 2021, selling an estimated $19.6M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 20% of its $1.51B portfolio in Q1 2021.
  • Lombard Odier Asset Management (Switzerland) opened 278 new positions and closed 8 in Q1 2021.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value rose 70% quarter-over-quarter to $1.51B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2021, filed 17 May 2021.